MaaT Pharma SA (EPA:MAAT)
France
· Delayed Price · Currency is EUR 5.87
+0.01 (0.17%)
Apr 28, 2026, 5:35 PM CET
MaaT Pharma Revenue
In the year 2025, MaaT Pharma had annual revenue of 4.52M EUR with 40.67% growth. MaaT Pharma had revenue of 2.10M in the half year ending December 31, 2025, with 146.71% growth.
Revenue
4.52M
Revenue Growth
+40.67%
P/S Ratio
24.45
Revenue / Employee
80.79K
Employees
59
Market Cap
110.61M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Innate Pharma | 9.01M |
| Adocia | 3.85M |
| ABIONYX Pharma | 4.10M |
| Valerio Therapeutics Société anonyme | 1.83M |
| OSE Immunotherapeutics | 1.78M |
| Sensorion | 5.81M |
| Fermentalg | 13.38M |
| Transgene | 7.21M |